Controlled release of nitric oxide for enhanced tumor drug delivery and reduction of thrombosis risk

Abstract

Antiplatelet nanoparticles co-loaded with l-arginine (LA) and photosensitizer IR783 were established for local NO release to inhibit tumor-associated platelets activation, suppress thrombosis and increase tumoral accumulation of the nanoagent.